Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × Tretinoin × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 4 Lymphoma, T-Cell, Cutaneous 2 Skin Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Multiple Myeloma 1 Lymphoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1

Interventions

pembrolizumab 16 lenvatinib 5 trametinib 2 dabrafenib 2 epacadostat 1 durvalumab 1 Tretinoin 1 Temozolomide 1 Paclitaxel 1 Nivolumab 1 Ipilimumab 1 Dacarbazine 1 DS-8273a 1 Carboplatin 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04305041 2025-08-29

KEYMAKER-U02

Merck Sharp & Dohme LLC

Phase 1/2 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡